Control of albuminuria in overt diabetic nephropathy: durability counts

被引：7
|
作者：
Glassock, Richard J. [1 ,2 ]
机构：
[1] Univ Calif Los Angeles, Geffen Sch Med, Los Angeles, CA 90095 USA
[2] 8 Bethany, Laguna Niguel, CA 92677 USA
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2016年 / 31卷 / 09期
关键词：
KIDNEY-DISEASE; MICROALBUMINURIA; PREDICTOR; METAANALYSIS; THERAPY;
D O I：
10.1093/ndt/gfv462
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
aEuro broken vertical bar The crucial point deserving of emphasis is that the enhancement as well as the durability of a decline in albuminuria with ARB treatment is an important surrogate for favorable outcomesaEuro broken vertical bar.
引用
收藏
页码：1371 / 1373
页数：3
相关论文
共 50 条
  • [21] Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy
    Satko, SG
    Langefeld, CD
    Daeihagh, P
    Bowden, DW
    Rich, SS
    Freedman, BI
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (03) : 489 - 494
  • [22] Diabetic Kidney Disease Without Albuminuria: A New Entity in Diabetic Nephropathy
    Ahmadi, Nooshin
    Amouzegar, Atefeh
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2024, 18 (01) : 1 - 8
  • [23] Urinary biomarkers for early diabetic nephropathy: beyond albuminuria
    Lee, So-Young
    Choi, Mary E.
    PEDIATRIC NEPHROLOGY, 2015, 30 (07) : 1063 - 1075
  • [24] Albuminuria: A target for treatment of type 2 diabetic nephropathy
    de Zeeuw, Dick
    SEMINARS IN NEPHROLOGY, 2007, 27 (02) : 172 - 181
  • [25] Urinary biomarkers for early diabetic nephropathy: beyond albuminuria
    So-Young Lee
    Mary E. Choi
    Pediatric Nephrology, 2015, 30 : 1063 - 1075
  • [26] REDUCTION IN ALBUMINURIA PREDICTS DIMINISHED PROGRESSION IN DIABETIC NEPHROPATHY
    ROSSING, P
    HOMMEL, E
    SMIDT, UM
    PARVING, HH
    KIDNEY INTERNATIONAL, 1994, 45 : S145 - S149
  • [27] MONITORING OF DIABETIC NEPHROPATHY BY DETERMINATIONS OF MICRO-ALBUMINURIA
    KREMPF, M
    RICOLLEAU, G
    MURAT, A
    DUROSTU, H
    CHARBONNEL, B
    GUILLON, J
    PRESSE MEDICALE, 1984, 13 (46): : 2817 - 2817
  • [28] Pioglitazone mitigates inflammation in patients with overt diabetic nephropathy
    Williams R.
    Nature Clinical Practice Nephrology, 2006, 2 (5): : 237 - 237
  • [29] Glomerular permselectivity in early stages of overt diabetic nephropathy
    Andersen, S
    Blouch, K
    Bialek, J
    Deckert, M
    Parving, HH
    Myers, BD
    KIDNEY INTERNATIONAL, 2000, 58 (05) : 2129 - 2137
  • [30] Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia
    Aso, Y
    Yoshida, N
    Okumura, K
    Wakabayashi, S
    Matsutomo, R
    Takebayashi, K
    Inukai, T
    CLINICA CHIMICA ACTA, 2004, 348 (1-2) : 139 - 145
12345